📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Sulfoxythiocarbamate S-4 inhibits HSP90 in human cutaneous squamous cell carcinoma cells. (2020)

First Author: Zhang Y

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejphar.2020.173609

PubMed Identifier: 33031796

Publication URI: http://europepmc.org/abstract/MED/33031796

Type: Journal Article/Review

Volume: 889

Parent Publication: European journal of pharmacology

ISSN: 0014-2999